Utilization of coronary artery bypass grafting with combined or staged carotid revascularization in a national sample

Tomás Daviú-Molinari1, Jashank Sharma1, Claire Ferguson1

  • 1Department of Surgery, State University of New York, Downstate Health Sciences University, Brooklyn, NY.

Journal of Vascular Surgery
|February 21, 2025
PubMed

Insights

Concurrent carotid and coronary artery bypass graft (CABG) procedures, including CEA and CAS, saw a significant decrease in utilization over two decades. This trend persisted regardless of whether procedures were staged or combined, impacting resource allocation and guideline planning.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Health Services Research

Background:

  • Co-prevalent carotid and coronary artery disease often necessitates combined revascularization strategies.
  • Carotid endarterectomy (CEA) or stenting (CAS) alongside coronary artery bypass graft (CABG) are common treatment approaches.
  • Uncertainty exists regarding the utilization frequency of these combined procedures.

Purpose of the Study:

  • To analyze trends in the volume of concurrent CABG and carotid revascularization (CEA/CAS) over a 20-year period.
  • To identify factors influencing the utilization of staged versus combined CABG/CEA/CAS procedures.
  • To describe changes in procedural volume over time and by hospital type.

Main Methods:

  • Utilized a nationally representative cohort from the National Inpatient Sample (1998-2020).
  • Included patients undergoing concurrent CABG with either CEA or CAS (staged or combined).
  • Employed Poisson regression to identify predictors of procedure volume and analyzed trends.

Main Results:

  • Analyzed 12,260 patients; 79.1% had staged and 20.9% had combined procedures.
  • CEA was more frequent than CAS in both staged (97.5%) and combined (91.7%) groups (P < .001).
  • Concurrent procedure volume decreased by 7% annually; increased in urban/teaching hospitals.

Conclusions:

  • Utilization of concurrent CABG/CEA and CABG/CAS operations significantly decreased over the past two decades.
  • The decline was consistent across both staged and combined procedural strategies.
  • Findings necessitate consideration for resource allocation and future clinical guideline development.
Abstract